RTK inhibition: Looking for the right pathways toward a miracle

Future Oncology

Volumn 8, Issue 11, 2012, Pages 1397-1400

  Xie, Qian ^a   Vande Woude, George F ^a   Berens, Michael E ^b  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

bevacizumab; drug resistance; glioblastoma; invasion; MET; vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN INTERACTION; TUMOR CELL; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 84869151154     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.130     Document Type: Article

References (12)

1. Lu KV, Chang JP, Parachoniak CA et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/ VEGFR2 complex. Cancer Cell 22(1), 21-35 (2012).
2. Phillips HS, Kharbanda S, Chen R et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173 (2006). (Pubitemid 43357943)
3. Zinn PO, Mahajan B, Sathyan P et al. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS ONE 6, e25451 (2011).
4. Turke AB, Zejnullahu K, Wu YL et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell 17, 77-88 (2010).
5. Straussman R, Morikawa T, Shee K et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487, 500-504 (2012).
6. Wilson TR, Fridlyand J, Yan Y et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 487, 505-509 (2012).
7. Xie Q, Bradley R, Kang L et al. Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma. Proc. Natl Acad. Sci. USA 109, 570-575 (2012).
8. Snuderl M, Fazlollahi L, Le LP et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20, 810-817 (2011).
9. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E. Ligand-independent activation of c-Met by fibronectin and alpha(5) beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30, 1566-1576 (2011).
10. Abounader R, Laterra J. Scatter factor/ hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro. Oncol. 7, 436-451 (2005). (Pubitemid 41555616)
11. Wen PY. American Society of Clinical Oncology 2010: Report of selected studies from the CNS tumors section. Expert Rev. Anticancer Ther. 10, 1367-1369 (2010).
12. Kaiser J. Profile: Bert Vogelstein. Cancer genetics with an edge. Science 337, 282-284 (2012).